News – One result:
Bartlit Beck Wins Inter Partes Review (IPR) Trial for Gilead Sciences, Inc.
[PDF] ... “[r]epresentative compounds.” Ex. 1007, 26:22–27:7. According to Petitioner, all but one of these compounds ... disclosures and claims of . . . NP2.” Id. (citing Ex. 1011 ¶ 119). For similar reasons, Petitioner also contends that neither P1 ...
Additional Documents 1 – 5 of 12:
... Deepwater Horizon Joint Investigation Team, July 19, 2010, 275. 119 John Gisclair (Halliburton), interview with Commission staff, September ... the Deepwater Horizon Joint Investigation Team, October 7, 2010, part 2, 119. 11 Internal BP document (BP-HZN-CEC ...
... . Trapilo, 130 F.3d 547 (2d Cir. 1997)............................................................................6, 7 Verlinden B.V. v. Central Bank of Nigeria, 461 ... the instant case”), cert. denied, 525 U.S. 812, 119 S.Ct. 45, 142 L.Ed.2d 35 (1998); ...
... 112. See Becton Brief, supra note 7, at 5, 7, 30. LEACHFINAL.DOC 2004] 3/5 ... crucial to the development of this confidence.”119 The emphasis on racial sensitivity as a ... need. 123. See Becton Brief, supra note 7, at 28 (“[P]reparing officer candidates for ...
... suppress certain evidence would have been “fruitless.” Id. at 119–20. The Oregon Court of Appeals “affirmed without opinion.” ... Together these cases demonstrate that it is appropriate for 7 I note that the majority opinion is utterly inconsistent ...
... ". (JTX3 at 8; Simon Tr. at 119) DNG had been used safely since ... JTX20 ("First Endrikat Declaration") at 1-7; JTX265 ("Second Endrikat Declaration") at 1523 ; ... consisting of a pharmaceutically acceptable placebo; 7 Neither Bayer nor Watson contends there ...